Literature DB >> 33375465

Aberrant Splicing in GJB1 and the Relevance of 5' UTR in CMTX1 Pathogenesis.

Federica Boso1,2, Federica Taioli1, Ilaria Cabrini1, Tiziana Cavallaro3, Gian Maria Fabrizi1,3.   

Abstract

The second most common form of Charcot-Marie-Tooth disease (CMT) follows an X-linked dominant inheritance pattern (CMTX1), referring to mutations in the gap junction protein beta 1 gene (GJB1) that affect connexin 32 protein (Cx32) and its ability to form gap junctions in the myelin sheath of peripheral nerves. Despite the advances of next-generation sequencing (NGS), attention has only recently also focused on noncoding regions. We describe two unrelated families with a c.-17+1G>T transversion in the 5' untranslated region (UTR) of GJB1 that cosegregates with typical features of CMTX1. As suggested by in silico analysis, the mutation affects the regulatory sequence that controls the proper splicing of the intron in the corresponding mRNA. The retention of the intron is also associated with reduced levels of the transcript and the loss of immunofluorescent staining for Cx32 in the nerve biopsy, thus supporting the hypothesis of mRNA instability as a pathogenic mechanism in these families. Therefore, our report corroborates the role of 5' UTR of GJB1 in the pathogenesis of CMTX1 and emphasizes the need to include this region in routine GJB1 screening, as well as in NGS panels.

Entities:  

Keywords:  5′ UTR; CMT; Charcot-Marie-Tooth; Connexin 32; GJB1; X-linked Charcot-Marie-Tooth (CMTX1); noncoding; splicing

Year:  2020        PMID: 33375465     DOI: 10.3390/brainsci11010024

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  2 in total

Review 1.  Mechanisms and Treatments in Demyelinating CMT.

Authors:  Vera Fridman; Mario A Saporta
Journal:  Neurotherapeutics       Date:  2021-11-08       Impact factor: 6.088

2.  Nerve Biopsy in Peripheral Neuropathies: Not All Water Is under the Bridge.

Authors:  Marco Luigetti; Andrea Di Paolantonio
Journal:  Brain Sci       Date:  2021-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.